Your weekly roundup of the latest news from Drug Topics®.
Most pharmacies are now utilizing text message programs for their customers. How can they be fully utilized, and what is the next step?
The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?
The FDA is working quickly to address shortages of the form used in nebulizers.
Investigators found significant associations between GI-PACS and multi-system concomitant symptoms.
Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days.